Loading...

PODCAST

Medtelligence

Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.

science & medicine medicine

All Episodes

00:00:00

Case-Based Management of Hyperkalemia to Optimize...

Medtelligence ·

2024/02/26

Host: Mikhail Kosiborod, MDGuest: Biff F. Palmer, MD Delve into refining the management of hyperkalemia in CKD patients and their associated comorbidities, striking a delicate balance that preserves guideline-recommended RAASi therapy. Join Dr. Biff Palmer and Dr. Mikhail Kosiborod as they guide the exploration of novel potassium binders for optimal hyperkalemia management, all while upholding the integrity of established treatment guidelines.

en

00:00:00

Challenging TAVR Cases

Medtelligence ·

2024/01/31

Host: Renuka Jain, MD Guest: Steven Yakubov, MD, MSCAI, FACC The Changing TAVR Landscape" is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial

en

00:00:00

Putting Data into Clinical Practice

Medtelligence ·

2024/01/31

Host: Pam R. Taub, MD, FACC, FASPC Guest: Steven Yakubov, MD, MSCAI, FACC The Changing TAVR Landscape" is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical

en

00:00:00

It’s All About Patient Identification

Medtelligence ·

2024/01/31

Host: Renuka Jain, MD The Changing TAVR Landscape" is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial data.

en

00:00:00

New TAVR Data – New TAVR Talk Track

Medtelligence ·

2024/01/31

Host: Hemal Gada, MD The Changing TAVR Landscape" is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial data.

en

00:00:00

The BeAT Goes On: New Data on Improving Symptoms in...

Medtelligence ·

2024/01/26

Host: William T. Abraham, MD, FACP, FACC, FAHA, FESC, FRCPE Guest: Georges Chahoud, MD, FACC, FAHA, FHFSA, FASE Guest: Patrick J. McCann, MD Even with guideline-directed medical therapy, or GDMT, many patients with heart failure are limited in their daily activities, due to increasing symptoms and reduced functionality. However, new data from BeAT-HF, a clinical trial that examines the long-term effects of baroreflex activation therapy, or BAT, shows that BAT may provide

en

00:00:00

Complementary Treatment for Uncontrolled...

Medtelligence ·

2024/01/08

Host: Raymond Townsend, MD Despite many available drug therapies, patients with hypertension continue to experience elevated blood pressures, putting them at risk for cardiovascular-related morbidities and mortality. However, renal denervation, a minimally invasive procedure, has been shown to result in sustained and durable reductions in blood pressure. Find out what this approach could mean for your patients.

en

00:00:00

Treating ATTR-CM With a Novel Therapeutic Approach:...

Medtelligence ·

2023/12/11

Host: Martha Grogan, MD, FACP, FACC Guest: Marianna Fontana, MD Guest: Nitasha Sarswat, MD Once considered rare and untreatable, amyloid transthyretin (ATTR) amyloidosis with cardiomyopathy (ATTR-CM) has increased in incidence over the last decade and is now a treatable condition. This is partly due to our better understanding of the biology of the disease and recognition of its comorbid or co-occurring conditions in both cardiac and noncardiac patients with cardiac

en

00:00:00

Hyperkalemia in CKD and HFrEF…What Am I Missing?

Medtelligence ·

2023/11/17

Host: George L. Bakris, MD, FAHA, FASN Guest: David Bushinsky, MD Guest: Lars Lund, MD Hyperkalemia is a limiting factor when treating patients with heart failure and CKD on RAASi therapy. It’s especially challenging when these patients are on chronic hemodialysis. Join Drs. George Bakris, David Bushinsky, and Lars Lund as they identify the barriers of optimal treatment in patients on hemodialysis and discuss the real-world evidence using potassium-lowering agents in

en

00:00:00

A Practical Look at Cardiorenal Protection for CKD in...

Medtelligence ·

2023/10/18

Host: Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC Guest: Maria Luiza Caramori, MD, PhD, MSc Guest: Ana Maria Cebrián-Cuenca, MD, PhD Guest: Pam R. Taub, MD, FACC, FASPC Optimal treatment with guideline-directed therapies, including RAS inhibitors, SGLT2 inhibitors, and nonsteroidal MRAs, is paramount in preventing progressive renal dysfunction and cardiorenal events in patients with chronic kidney disease and type 2 diabetes. As the patient becomes more

en

00:00:00

A Multidisciplinary Approach to Managing Potassium...

Medtelligence ·

2023/10/09

Host: Antoni Bayés-Genís, MD, PhD, FESC, FHFA Guest: Patrick Rossignol, MD, PhD Heart failure and chronic kidney disease can go hand in hand in your patients, and when they do, there are often added comorbidities such as diabetes. If your patients on RAASi therapy develop hyperkalemia, what should you do? Join Drs. Patrick Rossignol and Antoni Bayés-Genís as they consult on a patient with heart failure who has multiple comorbidities and discuss the impact of hyperkalemia in these

en

00:00:00

Bridging the Gap to Care: What You Need to Know About...

Medtelligence ·

2023/09/13

Guest: Mazen Hanna, MD Guest: Marianna Fontana, MD Once thought to be a rare disease, transthyretin amyloidosis that results in cardiomyopathy (ATTR-CM) remains a challenge to diagnose and treat. In this discussion, Drs. Mazen Hanna and Marianna Fontana provide expert advice on imaging techniques to diagnose ATTR-CM, including recognizing diagnostic “red flags.” They also review recent clinical trial data of current and potential therapeutics for ATTR-CM, so listen in to find out

en

00:00:00

Improving Symptoms in Patients with HFrEF Using Novel...

Medtelligence ·

2023/08/07

Host: Nirav Y. Raval, MD, FACC Guest: Gurusher Panjrath, MD, FACC, FAHA, FHFSA Despite the use of guideline-directed medical therapy, many patients with heart failure continue to have worsening symptoms. Enter baroreflex activation therapy, or BAT, an implantable FDA-approved cardiac autonomic modulation device. Listen in as Drs. Nirav Raval and Gurusher Panjrath explore data on its positive effects on exercise capacity, functional status, and quality of life. Do you know which of

en

00:00:00

What’s the Consensus on Cardiorenal Protection for...

Medtelligence ·

2023/07/13

Host: Tessa Laubscher, MBChB, CCFP, FCFP Guest: George L. Bakris, MD, FAHA, FASN Guest: Mikhail Kosiborod, MD Managing chronic kidney disease (CKD) and type 2 diabetes (T2D) with multiple medications has become a challenge, and a multidisciplinary approach is needed to achieve optimal cardiorenal outcomes. Join Drs. George Bakris, Mikhail Kosiborod, and Tessa Laubscher as they discuss initiating consensus-based nonsteroidal MRA therapy in their patients with CKD and T2D.

en

00:00:00

Applying Evidence to Practice: What Can We Learn from...

Medtelligence ·

2023/07/07

Host: Piotr Ponikowski, MD, PhD, FESC, FHFA Guest: Robert J. Mentz, MD, FHFSA, FACC, FAHA While multiple clinical trials demonstrated a positive impact on patient outcomes with IV iron therapy in patients with HFrEF and iron deficiency, few have addressed the long-term effects of IV iron treatment on morbidity, mortality, and exercise tolerance in these patients. Join Dr. Robert Mentz and Dr. Piotr Ponikowski as they discuss the design of the HEART-FID trial and its potential

en

00:00:00

Hyperkalemia: Is It Still a Challenge in 2023?

Medtelligence ·

2023/06/30

Host: Ileana L. Piña, MD, MPH, FAHA, FACC Guest: Javed Butler, MD, MBA, MPH Guest: Patrick Rossignol, MD, PhD With more effective ways to manage hyperkalemia, is it still a challenge in 2023? Chairperson Ileana Piña, MD, and faculty members cardiologist Javed Butler, MD, and nephrologist Patrick Rossignol, MD, use case-based vignettes to provide expert analysis regarding hyperkalemia in patients with HFrEF who are on RAASi therapy. Tune in for insights on applying clinical

en

00:00:00

Tackling Fluid Overload in Patients with Heart...

Medtelligence ·

2023/05/15

Host: Javed Butler, MD, MBA, MPH Guest: John P. Boehmer, MD Heart failure contributes to more than 3 million hospital admissions, resulting in a considerable economic burden. Despite significant developments to advance treatment, hospital readmission rates also remain high. Join Drs. Javed Butler and John Boehmer as they discuss fluid overload in patients with heart failure and explore recent clinical evidence in remote monitoring strategies to improve patient outcomes.

en

00:00:00

Expert Review of Case Studies for Autoantibody...

Medtelligence ·

2018/04/27

Guest: Robert A. Baldor, MD Guest: Chadwick R. Johr, MD This innovative, 45-minute, case-based CME activity features two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. Using case studies, the faculty will explore diagnosis and management strategies to maximize patient care. In addition to the analysis of AI cases, key topics will be covered, including: Evaluation for suspected RA Combination serological

en

00:00:00

Autoantibody Testing for Connective Tissue Diseases:...

Medtelligence ·

2018/03/26

Guest: Robert A. Baldor, MD Guest: Chadwick R. Johr, MD This innovative, 30-minute, online activity features a Video Expert Dialogue with two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. The emphasis is on the unique role primary care providers play in diagnosing and managing AI and maximizing patient care. Topics include: Overview of connective tissue diseases and ANA testing ANA IFA and ELISA New tests

en

19 results

Similar Podcasts

天方烨谈

基因频道

This Week in Virology

Vincent Racaniello

Weird Things

Andrew Mayne

Homesteading and Permaculture by Paul Wheaton

paul wheaton

The Permaculture Podcast

Scott Mann